Passa al contenuto
Merck
Tutte le immagini(3)

Documenti fondamentali

Visualizza tutta la documentazione

M2015

Sigma-Aldrich

1-Stearoyl-rac-glycerol

≥99%

Sinonimo/i:

MG(18:0/0:0/0:0)[rac], 1-Monooctadecanoyl-rac-glycerol, rac-Glycerol 1-stearate, DL-α-Stearin, Monostearin

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(3)

About This Item

Formula condensata:
CH3(CH2)16COOCH2CH(OH)CH2OH
Numero CAS:
123-94-4
Peso molecolare:
358.56
Beilstein:
1728685
Numero CE:
204-664-4
Numero MDL:
MFCD00036186
Codice UNSPSC:
51191904
ID PubChem:
24896595
NACRES:
NA.25

Origine biologica

synthetic (organic)

Livello qualitativo

200

Saggio

≥99%

Stato

powder

Gruppo funzionale

phospholipid

Tipo di lipide

neutral glycerides

Condizioni di spedizione

ambient

Temperatura di conservazione

−20°C

Stringa SMILE

CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO

InChI

1S/C21H42O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(24)25-19-20(23)18-22/h20,22-23H,2-19H2,1H3
VBICKXHEKHSIBG-UHFFFAOYSA-N

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Categorie correlate

Applicazioni

Monostearin (1-Stearoyl-rac-glycerol) is used in the development of drug delivery vehicles such as nanoparticles and microemulsions.

Codice della classe di stoccaggio

11 - Combustible Solids

Classe di pericolosità dell'acqua (WGK)

WGK 1

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Dispositivi di protezione individuale

Eyeshields, Gloves, type N95 (US)

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number
SLCJ8588
SLCJ3592
SLBX9801
SLBS9780
SLBK9411V

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Cerca un COA

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 6

1 of 6

3-Palmitoyl-sn-glycerol ≥99.0% (TLC)

Sigma-Aldrich

76184

3-Palmitoyl-sn-glycerol

Monononadecanoin analytical standard

Supelco

02193

Monononadecanoin

USP

USP

1446000

Monoglycerides

Glyceryl 1,3-dipalmitate ≥99%

Sigma-Aldrich

D1639

Glyceryl 1,3-dipalmitate

EN 14105:2003 Monoglyceride Stock Solution 10 mg/mL each component in pyridine, analytical standard

Supelco

49446-U

EN 14105:2003 Monoglyceride Stock Solution

rac-1,2-Distearoylglycerol ≥99% (GC)

Sigma-Aldrich

43697

rac-1,2-Distearoylglycerol

Sheng Tan et al.
Drug design, development and therapy, 11, 3519-3529 (2017-12-22)
Erlotinib (ETB) is a well-established therapeutic for non-small-cell lung cancer (NSCLC). To overcome drug resistance and severe toxicities in the clinical application, redox-responsive and pH-sensitive nanoparticle drug delivery systems were designed for the encapsulation of ETB. Poly(acrylic acid)-cystamine-oleic acid (PAA-ss-OA)
Maria Christina Camasmie Peters et al.
Journal of drug targeting, 28(3), 259-270 (2019-09-07)
Nanocrystals and lipid-based nanosystems have the potential to play a crucial role in a significant shift in the treatment of ophthalmic diseases. These drug delivery systems allow overcoming the barriers imposed by anatomy and physiology of the organ of vision.
Min Fang et al.
International journal of nanomedicine, 7, 5395-5404 (2012-10-24)
Curcumin has a variety of pharmacological effects. However, poor water solubility and low oral bioavailability limit its clinical utility. A delivery system for nanostructured lipid carriers has been reported to be a promising approach to enhancing the oral absorption of
Laizhu Zhang et al.
Drug delivery, 23(9), 3529-3537 (2016-06-25)
Transdermal local anesthesia is one of the most applied strategies to avoid systemic adverse effects; there is an appealing need for a prolonged local anesthetic that would provide better bioavailability and longer pain relief with a single administration. Layer-by-layer (LBL)
Maria Chountoulesi et al.
Brain sciences, 10(6) (2020-06-06)
Multiple sclerosis (MS) is a chronic, autoimmune, neurodegenerative disease of the central nervous system (CNS) that yields to neuronal axon damage, demyelization, and paralysis. Although several drugs were designed for the treatment of MS, with some of them being approved
Visualizza tutti i documenti correlati

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.